Potentiometric and spectrophotometric investigation of copper diclofenac as an anti inflammatory drug for the treatment of Rheumatoid Arthritis
Includes bibliographical references. === Copper and Diclofenac (DCL) separately, are used to alleviate inflammation associated with RA. It has been postulated that their combination would have a synergistic effect i.e., their combination would be more effective than when administered independently....
Main Author: | Nama, Nelisa Petronella Vuyo |
---|---|
Other Authors: | Jackson, Graham Ellis |
Format: | Dissertation |
Language: | English |
Published: |
University of Cape Town
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/6349 |
Similar Items
-
Design of novel copper(II) based anti-inflammatory drugs for the elevation associated with Rheumatoid Arthritis
by: Mhlambiso, Zizile
Published: (2014) -
Dipeptides as potential anti-flammatory drugs for rheumatoid arthritis
by: Mohajane, Mamohale
Published: (2014) -
Non-steroidal anti-inflammatory drugs and the cell-mediated immune response in rheumatoid arthritis
by: Jenkins, R.
Published: (1984) -
Metal ion equilibria in biofluids - copper and rheumatoid arthritis
by: Kelly, Mark Joseph
Published: (2014) -
Potentiometric and spectrophotometric investigation of the complexes of mercury (II), copper (II), and nickel (II) with triethylenetraamine and nickel (II) with a mixture of triethylenetraamine and oxalate ions /cby Paula Catalano Dunnigan
by: Dunnigan, Paula Catalano
Published: (1975)